Bluejay Diagnostics, Inc. - BJDX
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Mar 11, 2026 | SCHEDULE 13D | — | 1.13% | 972,000 | View |
| Mar 11, 2026 | SCHEDULE 13D | — | 1.13% | 972,000 | View |
| Mar 11, 2026 | SCHEDULE 13D | — | 3.65% | 972,000 | View |
| Feb 18, 2026 | SCHEDULE 13G | Armistice Capital, LLC | 9.99% | 194,132 | View |
| Feb 18, 2026 | SCHEDULE 13G | Steven Boyd | 9.99% | 194,132 | View |
| Feb 17, 2026 | SCHEDULE 13G | Armistice Capital, LLC | 9.99% | 194,132 | View |
| Feb 17, 2026 | SCHEDULE 13G | Steven Boyd | 9.99% | 194,132 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Mitchell P. Kopin | 4.99% | 91,537 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Daniel B. Asher | 4.99% | 91,537 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Intracoastal Capital LLC | 4.99% | 91,537 | View |
| Feb 05, 2026 | SCHEDULE 13G | Northstrive Fund II LP | 1.55% | 11,000 | View |
| Feb 05, 2026 | SCHEDULE 13G | Braeden Lichti | 5.01% | 35,500 | View |
| Feb 05, 2026 | SCHEDULE 13G | Braeden Lichti | 5.01% | 35,500 | View |
| Feb 05, 2026 | SCHEDULE 13G | Northstrive Fund II LP | 1.55% | 11,000 | View |
| Oct 16, 2025 | SCHEDULE 13G | Mitchell P. Kopin | 9.99% | 177,580 | View |
| Oct 16, 2025 | SCHEDULE 13G | Daniel B. Asher | 9.99% | 177,580 | View |
| Oct 16, 2025 | SCHEDULE 13G | INTRACOASTAL CAPITAL, LLC | 9.99% | 177,580 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.